Dietary conjugated linoleic acid did not alter immune status in young healthy women

D. S. Kelley, P. C. Taylor, I. L. Rudolph, P. Benito, G. J. Nelson, B. E. Mackey, Kent L Erickson

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The purpose of this study was to examine whether conjugated linoleic acid (CLA) supplementation in human diets would enhance indices of immune status as reported by others for animal models. Seventeen women, 20-41 yr, participated in a 93-d study conducted in two cohorts of 9 and 8 women at the Metabolic Research Unit of Western Human Nutrition Research Center. Seven subjects were fed the basal diet (19, 30, and 51% energy from protein, fat, and carbohydrate, respectively) throughout the study. The remaining 10 subjects were fed the basal diet for the first 30 d, followed by 3.9 g CLA (Tonalin)/d for the next 63 d. CLA made up 65% of the fatty acids in the Tonalin capsules, with the following isomeric composition: t10, c12, 22.6%; c11, t13, 23.6%; c9, t11, 17.6%; t8, c10, 16.6%; and other isomers 19.6%. Most indices of immune response were tested at weekly intervals, three times at the end end of each period (stabilization/intervention); delayed-type hypersensitivity (DTH) to a panel of six recall antigens was tested on study day 30 and 90; all subjects were immunized on study day 65 with an influenza vaccine, and antibody titers were examined in the sera collected on day 65 and 92. None of the indices of immune status tested (number of circulating white blood cells, granulocytes, monocytes, lymphocytes, and their subsets, lymphocytes proliferation in response to phytohemagglutinin, and influenza vaccine, serum influenza antibody titers, and DTH response) were altered during the study in either dietary group. Thus, in contrast to the reports with animal models, CLA feeding to young healthy women did not alter any of the indices of immune status tested. These data suggest that short-term CLA supplementation in healthy volunteers is safe, but it does not have any added benefit to their immune status.

Original languageEnglish (US)
Pages (from-to)1065-1071
Number of pages7
JournalLipids
Volume35
Issue number10
StatePublished - 2000

Fingerprint

Conjugated Linoleic Acids
conjugated linoleic acid
Nutrition
influenza
delayed hypersensitivity
Lymphocytes
Influenza Vaccines
Delayed Hypersensitivity
Diet
Animals
Animal Models
animal models
diet
vaccines
nutrition research
antibodies
Antibodies
phytohemagglutinin
Lymphocyte Subsets
human nutrition

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Food Science
  • Biochemistry

Cite this

Kelley, D. S., Taylor, P. C., Rudolph, I. L., Benito, P., Nelson, G. J., Mackey, B. E., & Erickson, K. L. (2000). Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids, 35(10), 1065-1071.

Dietary conjugated linoleic acid did not alter immune status in young healthy women. / Kelley, D. S.; Taylor, P. C.; Rudolph, I. L.; Benito, P.; Nelson, G. J.; Mackey, B. E.; Erickson, Kent L.

In: Lipids, Vol. 35, No. 10, 2000, p. 1065-1071.

Research output: Contribution to journalArticle

Kelley, DS, Taylor, PC, Rudolph, IL, Benito, P, Nelson, GJ, Mackey, BE & Erickson, KL 2000, 'Dietary conjugated linoleic acid did not alter immune status in young healthy women', Lipids, vol. 35, no. 10, pp. 1065-1071.
Kelley DS, Taylor PC, Rudolph IL, Benito P, Nelson GJ, Mackey BE et al. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids. 2000;35(10):1065-1071.
Kelley, D. S. ; Taylor, P. C. ; Rudolph, I. L. ; Benito, P. ; Nelson, G. J. ; Mackey, B. E. ; Erickson, Kent L. / Dietary conjugated linoleic acid did not alter immune status in young healthy women. In: Lipids. 2000 ; Vol. 35, No. 10. pp. 1065-1071.
@article{0cc46dd893094a7cb79d9dcd2f15eb84,
title = "Dietary conjugated linoleic acid did not alter immune status in young healthy women",
abstract = "The purpose of this study was to examine whether conjugated linoleic acid (CLA) supplementation in human diets would enhance indices of immune status as reported by others for animal models. Seventeen women, 20-41 yr, participated in a 93-d study conducted in two cohorts of 9 and 8 women at the Metabolic Research Unit of Western Human Nutrition Research Center. Seven subjects were fed the basal diet (19, 30, and 51{\%} energy from protein, fat, and carbohydrate, respectively) throughout the study. The remaining 10 subjects were fed the basal diet for the first 30 d, followed by 3.9 g CLA (Tonalin)/d for the next 63 d. CLA made up 65{\%} of the fatty acids in the Tonalin capsules, with the following isomeric composition: t10, c12, 22.6{\%}; c11, t13, 23.6{\%}; c9, t11, 17.6{\%}; t8, c10, 16.6{\%}; and other isomers 19.6{\%}. Most indices of immune response were tested at weekly intervals, three times at the end end of each period (stabilization/intervention); delayed-type hypersensitivity (DTH) to a panel of six recall antigens was tested on study day 30 and 90; all subjects were immunized on study day 65 with an influenza vaccine, and antibody titers were examined in the sera collected on day 65 and 92. None of the indices of immune status tested (number of circulating white blood cells, granulocytes, monocytes, lymphocytes, and their subsets, lymphocytes proliferation in response to phytohemagglutinin, and influenza vaccine, serum influenza antibody titers, and DTH response) were altered during the study in either dietary group. Thus, in contrast to the reports with animal models, CLA feeding to young healthy women did not alter any of the indices of immune status tested. These data suggest that short-term CLA supplementation in healthy volunteers is safe, but it does not have any added benefit to their immune status.",
author = "Kelley, {D. S.} and Taylor, {P. C.} and Rudolph, {I. L.} and P. Benito and Nelson, {G. J.} and Mackey, {B. E.} and Erickson, {Kent L}",
year = "2000",
language = "English (US)",
volume = "35",
pages = "1065--1071",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Dietary conjugated linoleic acid did not alter immune status in young healthy women

AU - Kelley, D. S.

AU - Taylor, P. C.

AU - Rudolph, I. L.

AU - Benito, P.

AU - Nelson, G. J.

AU - Mackey, B. E.

AU - Erickson, Kent L

PY - 2000

Y1 - 2000

N2 - The purpose of this study was to examine whether conjugated linoleic acid (CLA) supplementation in human diets would enhance indices of immune status as reported by others for animal models. Seventeen women, 20-41 yr, participated in a 93-d study conducted in two cohorts of 9 and 8 women at the Metabolic Research Unit of Western Human Nutrition Research Center. Seven subjects were fed the basal diet (19, 30, and 51% energy from protein, fat, and carbohydrate, respectively) throughout the study. The remaining 10 subjects were fed the basal diet for the first 30 d, followed by 3.9 g CLA (Tonalin)/d for the next 63 d. CLA made up 65% of the fatty acids in the Tonalin capsules, with the following isomeric composition: t10, c12, 22.6%; c11, t13, 23.6%; c9, t11, 17.6%; t8, c10, 16.6%; and other isomers 19.6%. Most indices of immune response were tested at weekly intervals, three times at the end end of each period (stabilization/intervention); delayed-type hypersensitivity (DTH) to a panel of six recall antigens was tested on study day 30 and 90; all subjects were immunized on study day 65 with an influenza vaccine, and antibody titers were examined in the sera collected on day 65 and 92. None of the indices of immune status tested (number of circulating white blood cells, granulocytes, monocytes, lymphocytes, and their subsets, lymphocytes proliferation in response to phytohemagglutinin, and influenza vaccine, serum influenza antibody titers, and DTH response) were altered during the study in either dietary group. Thus, in contrast to the reports with animal models, CLA feeding to young healthy women did not alter any of the indices of immune status tested. These data suggest that short-term CLA supplementation in healthy volunteers is safe, but it does not have any added benefit to their immune status.

AB - The purpose of this study was to examine whether conjugated linoleic acid (CLA) supplementation in human diets would enhance indices of immune status as reported by others for animal models. Seventeen women, 20-41 yr, participated in a 93-d study conducted in two cohorts of 9 and 8 women at the Metabolic Research Unit of Western Human Nutrition Research Center. Seven subjects were fed the basal diet (19, 30, and 51% energy from protein, fat, and carbohydrate, respectively) throughout the study. The remaining 10 subjects were fed the basal diet for the first 30 d, followed by 3.9 g CLA (Tonalin)/d for the next 63 d. CLA made up 65% of the fatty acids in the Tonalin capsules, with the following isomeric composition: t10, c12, 22.6%; c11, t13, 23.6%; c9, t11, 17.6%; t8, c10, 16.6%; and other isomers 19.6%. Most indices of immune response were tested at weekly intervals, three times at the end end of each period (stabilization/intervention); delayed-type hypersensitivity (DTH) to a panel of six recall antigens was tested on study day 30 and 90; all subjects were immunized on study day 65 with an influenza vaccine, and antibody titers were examined in the sera collected on day 65 and 92. None of the indices of immune status tested (number of circulating white blood cells, granulocytes, monocytes, lymphocytes, and their subsets, lymphocytes proliferation in response to phytohemagglutinin, and influenza vaccine, serum influenza antibody titers, and DTH response) were altered during the study in either dietary group. Thus, in contrast to the reports with animal models, CLA feeding to young healthy women did not alter any of the indices of immune status tested. These data suggest that short-term CLA supplementation in healthy volunteers is safe, but it does not have any added benefit to their immune status.

UR - http://www.scopus.com/inward/record.url?scp=0033734323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033734323&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 1065

EP - 1071

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 10

ER -